论文部分内容阅读
目的:对帕金森病患者使用美多巴结合普拉克索进行治疗并对其治疗效果进行探索。方法:对我院纳入的100例帕金森病患者进行研究,根据电脑产生的随机数列分为研究组和对照组,每组50例患者。对照组患者使用美多巴治疗,研究组患者使用美多巴联合普拉克索进行治疗。对两组患者的治疗效果、不良反应进行探究。结果:研究组患者的治疗总有效率显著高于对照组(P<0.05),经治疗研究组患者的UPDRSⅡ和UPDRSⅢ的评分低于对照组。结论:对帕金森病患者使用美多巴联合普拉克索进行治疗,患者的治疗效果显著,不良反应大大减少。
OBJECTIVE: To treat patients with Parkinson’s disease using metoparamin combined with pramipexole and to explore their therapeutic effect. Methods: One hundred patients with Parkinson’s disease included in our hospital were studied. According to random numbers generated by computer, the patients were divided into study group and control group, with 50 patients in each group. Patients in the control group received metoparand and patients in the study group were treated with metoparamin combined with pramipexole. The treatment of two groups of patients, adverse reactions to explore. Results: The total effective rate of study group was significantly higher than that of control group (P <0.05). The scores of UPDRS Ⅱ and UPDRS Ⅲ of the study group were lower than those of the control group. Conclusion: The treatment of patients with Parkinson’s disease with metoparamin combined with pramipexole, the treatment of patients with significant effect, greatly reduced adverse reactions.